EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Peritoneal Dialysis -Associated Fibrosis: Emerging Mechanisms and Therapeutic Opportunities

Narayan Prasad, Saurabh Chaturvedi, Harshit Singh, Mary Priyanka Udumula, Atul Rawat, Meyyappan Jeyakumar, Akhilesh Jaiswal, Sachin Kumar, Vikas Agarwal

Frontiers in Pharmacology · 22.08.2025 · 16

DOI: 10.3389/fphar.2025.1635624 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Frontiers in Pharmacology, online erschienen am 22.08.2025. Verfasst von Narayan Prasad und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology, Sanjay Gandhi Post Graduate Institute of Medical Sciences, Lucknow, Uttar Pradesh, India. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 201 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Peritoneal Dialysis (PD) requires a healthy and functional peritoneal membrane for adequate ultrafiltration and fluid balance, making it a vital treatment for patients with end-stage renal disease (ESRD). The spectrum of PD-associated peritoneal fibrosis encompasses a diverse range of collective mechanisms: peritoneal fibrogenesis, epithelial to mesenchymal transition (EMT), peritonitis, angiogenesis, sub-mesothelial immune cells infiltration, and collagen deposition in the sub-mesothelial compact zone of the membrane that accompany deteriorating membrane function. In this narrative review, we summarize the repertoire of current knowledge about the structure, function, and pathophysiology of the peritoneal membrane, focusing on biomolecular mechanisms and signalling pathways that potentiate the development and progression of peritoneal fibrosis. The article suggests future directions that could enhance our comprehension of the relationship between peritoneal membrane dysfunction and its fibrosis to elucidate the promising targets for therapeutic interventions. A thorough understanding of early events in pathophysiology closely associated with the inflammatory events in peritoneal fibrosis is the logical starting point for identifying new targets rather than concentrating on more downstream effects. Biomarkers are essential for monitoring the progression of peritoneal fibrosis and evaluating the effectiveness of therapeutic interventions. Biomarkers are evolving in concert with new targets and novel agents, and biomarker outcomes offer a means of monitoring the peritoneal membrane’s health. Recent approaches to reducing the etiologies of peritoneal membrane dysfunction, the impact of fibroblast switch, and peritoneal membrane events perturbing fibroblast function are explored and suggest using unique, effective therapeutic strategies to target peritoneal fibrosis and associated complications.

Schlagwörter

Stichwörter der Autor:innen

Smad/non-Smad signalingbiomarkersbiomechanical injury in peritoneal membraneepigenetics and altered gut microbiomeepithelial to mesenchymal transitionperitoneal dialysis solutions and inflammationperitoneal fibrogenesisperitonitis and peritoneal angiogenesis

Autor:innen und Institutionen

  • Department of Nephrology, Sanjay Gandhi Post Graduate Institute of Medical Sciences, Lucknow, Uttar Pradesh, India.
  • Department of Medical Laboratory Technology and Sciences, School of Allied Health Sciences, Delhi Pharmaceutical Sciences and Research University, New Delhi, India.
  • Department of Women's Health Services, Henry Ford Hospital, Henry Ford Cancer Institute, Detroit, MI, United States.
  • Department of Nephrology, Sir Ganga Ram Hospital, New Delhi, India.
  • Department of Clinical Immunology and Rheumatology, Sanjay Gandhi Post Graduate Institute of Medical Sciences, Lucknow, Uttar Pradesh, India.

Zitieren

APA

Prasad, N., Chaturvedi, S., Singh, H., Udumula, M. P., Rawat, A., Jeyakumar, M., Jaiswal, A., Kumar, S., & Agarwal, V. (2025). Peritoneal Dialysis -Associated Fibrosis: Emerging Mechanisms and Therapeutic Opportunities. Frontiers in Pharmacology, 16. https://doi.org/10.3389/fphar.2025.1635624

Vancouver

Prasad N, Chaturvedi S, Singh H, Udumula MP, Rawat A, Jeyakumar M, et al. Peritoneal Dialysis -Associated Fibrosis: Emerging Mechanisms and Therapeutic Opportunities. Frontiers in Pharmacology. 2025;16. doi:10.3389/fphar.2025.1635624

BibTeX
@article{Prasad2025,
  author = {Prasad, Narayan and Chaturvedi, Saurabh and Singh, Harshit and Udumula, Mary Priyanka and Rawat, Atul and Jeyakumar, Meyyappan and Jaiswal, Akhilesh and Kumar, Sachin and Agarwal, Vikas},
  title = {Peritoneal Dialysis -Associated Fibrosis: Emerging Mechanisms and Therapeutic Opportunities},
  journal = {Frontiers in Pharmacology},
  year = {2025},
  volume = {16},
  doi = {10.3389/fphar.2025.1635624}
}
Kostenlos starten →